Aktie A092730 NEOPHARM CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen NeoPharm CO., LTD.

Aktien

A092730

KR7092730001

A092730

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 16.05.2024 		% 5 Tage % 1. Jan.
26 200 KRW +5,01 % Intraday Chart für NeoPharm CO., LTD. +3,15 % +1,35 %
2023 NeoPharm CO., LTD. meldet Ergebnis für das erste Quartal bis zum 31. März 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023
NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding
NeoPharm CO., LTD. announced that it expects to receive KRW 31.970667276 billion in funding
Gpower, inc. cancelled the acquisition of 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park.
Gpower, inc. agreed to acquire 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park for approximately KRW 780 million.
HOPE BIOSCIENCES, INC. Acquires Worldwide Rights to Novel MERTK/AXL Inhibitor from Neopharm Co. Ltd
Han Bul Cosmetics Co., Ltd. and an individual completed the acquisition of 29.39% stake in Neopharm Co Ltd from Ahn, Yong-Chan and 7 individuals.
Han Bul Cosmetics Co., Ltd. and an individual signed a contract to acquire 29.39% stake in Neopharm Co Ltd from Yong-Chan Ahn and 7 individuals for KRW 72.8 billion.
Neopharm Co Ltd(KOSDAQ:A092730) added to S&P Global BMI Index
LEO Pharma A/S Enters Supply and Distribution Agreement with NeoPharm Co., Ltd. on Non-Prescription Skin Care Solutions
Neopharm Co Ltd's Equity Buyback announced on February 10, 2014 has expired.
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on February 10, 2014.
Neopharm Co Ltd authorizes a Buyback Plan.
Neopharm Co Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on July 9, 2013
Neopharm Co Ltd s Equity Buyback announced on July 9, 2013 has expired with 166,483 shares for KRW 1,007.08 million.
Neopharm Co Ltd announces an Equity Buyback
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A092730 Aktie
  4. Nachrichten NeoPharm CO., LTD.
  5. Andere Sprachen